MATINAS BIOPHARMA HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1789 USD | -1.43% |
|
-4.69% | -17.25% |
| 27/03 | Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024 | |
| 27/03 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Matinas BioPharma Holdings, Inc.
bba.4jOyi18hBGsebzcA4uKr0ASjn_X0xC8jqnAPPemfi6I.jkXr3RYSRwRPGnR2mK7phlbwqc27hRpl5hlsUpHJ3MmrZYf5NGNNKlkXeg~366468f73b49e0ec2b3c378703c7a309
Upcoming events on Matinas BioPharma Holdings, Inc.
Past events on Matinas BioPharma Holdings, Inc.
| 28/03/2024 02:00 am | Q4 2023 Earnings Call |
| 28/03/2024 01:35 am | Q4 2023 Earnings Release |
| 10/01/2024 12:30 am | Biotech Showcase |
| 09/11/2023 03:00 am | Q3 2023 Earnings Call |
| 09/11/2023 02:35 am | Q3 2023 Earnings Release |
| 01/11/2023 06:30 pm | Annual General Meeting |
| 19/10/2023 08:30 pm | ThinkEquity Conference |
| 13/10/2023 01:00 am | Dawson James Small Cap Growth Conference |
| 12/10/2023 05:42 pm | IDWeek Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 10/08/2023 01:35 am | Q2 2023 Earnings Release |
| 07/08/2023 | BTIG Virtual Biotechnology Conference |
| 15/05/2023 07:00 pm | JMP Securities Life Sciences Conference |
| 11/05/2023 02:00 am | Q1 2023 Earnings Call |
| 11/05/2023 01:35 am | Q1 2023 Earnings Release |
| 18/04/2023 | Clinical Microbiology & Infectious Diseases European Congress - Marisa H |
| 18/04/2023 | Clinical Microbiology & Infectious Diseases European Congress - David Boulware |
| 16/03/2023 02:00 am | Q4 2022 Earnings Call |
| 16/03/2023 01:35 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,09 0,11 -21.42% | 0,16 1,12 -85.82% | 0,03 0,36 -90.8% | 3,19 2,87 11.04% | 1,10 1,10 -0.18% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -18,7 -17,6 -6.34% | -24,0 -24,4 1.74% | -24,5 -24,9 1.65% | -24,3 -24,1 -0.63% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,9 -18,3 -3.47% | -24,2 -23,4 -3.37% | -24,7 -25,6 3.27% | -24,6 -25,8 4.8% | -23,8 -24,1 1.33% | -27,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -17,3 -0.35% | -22,4 -21,4 -4.94% | -23,3 -24,2 3.89% | -21,0 -24,1 12.71% | -22,9 -23,8 3.7% | -26,9 |
|
Net income Million USD | Released Forecast Spread | -18,3 -17,7 -3.34% | -23,2 -22,0 -5.84% | -23,7 -24,5 3.31% | -21,0 -24,1 12.71% | -22,9 -23,7 3.25% | -26,9 |
|
EPS USD | Released Forecast Spread | -0,13 -0,12 -5.41% | -0,12 -0,12 -4.35% | -0,11 -0,12 8.33% | -0,10 -0,11 9.09% | -0,11 -0,11 0% | -0,11 |
| Announcement Date | 09/03/20 | 29/03/21 | 08/03/22 | 15/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,45 - | 0,00 0,00 - | 1,06 0,06 1546.01% | 1,06 0,85 25.52% | 1,06 0,72 47.43% | 1,10 0,30 265.33% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -6,65 -7,10 6.35% | -7,65 -6,30 -21.48% | -5,84 -6,40 8.76% | -5,37 -5,80 7.36% | -5,39 -5,30 -1.64% | -5,49 -5,80 5.29% | |||||||
|
EBIT Million USD | Released Forecast Spread | -6,71 -7,56 11.13% | -7,72 -6,71 -15.05% | -5,93 -7,24 18.11% | -5,46 -6,31 13.4% | -5,48 -5,89 7.01% | -5,59 -5,90 5.32% | -6,16 -6,72 8.41% | -6,13 -6,21 1.23% | -5,89 -6,20 5.01% | -5,75 | -5,75 | -6,75 | -7,75 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,70 -7,64 12.33% | -5,98 -6,99 14.53% | -5,92 -7,23 18.07% | -5,46 -6,30 13.37% | -3,63 -5,89 38.28% | -5,51 -5,90 6.56% | -6,06 -6,75 10.21% | -6,06 -6,22 2.67% | -5,31 -6,20 14.22% | -5,70 | -5,70 | -6,70 | -7,70 |
|
Net income Million USD | Released Forecast Spread | -6,70 -7,64 12.33% | -5,98 -6,99 14.53% | -5,92 -7,23 18.07% | -5,46 -6,30 13.37% | -3,63 -5,89 38.28% | -5,51 -5,90 6.56% | -6,06 -6,72 9.88% | -6,06 -6,17 1.87% | -5,31 -6,10 12.85% | -5,70 | -5,70 | -6,70 | -7,70 |
|
EPS USD | Released Forecast Spread | -0,03 -0,04 20% | -0,03 -0,03 0% | -0,03 -0,03 7.69% | -0,03 -0,03 0% | -0,02 -0,03 25.01% | -0,03 -0,03 0% | -0,03 -0,03 0% | -0,03 -0,03 0% | -0,03 -0,03 0% | -0,03 | -0,03 | -0,03 | -0,03 |
| Announcement Date | 08/03/22 | 12/05/22 | 11/08/22 | 02/11/22 | 15/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 27/03/24 | - | - | - | - |
More events
Past sector events for Matinas BioPharma Holdings, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MTNB Stock
- Calendar Matinas BioPharma Holdings, Inc.
